@xconomy.com 1 year ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com 1 year ago
AgileCraft’s Exit, $45M for Ojo Labs, Intel Grants & More TX Tech
@xconomy.com 1 year ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com 1 year ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com 2 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@techcrunch.com 2 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq
@xconomy.com 2 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M